Skip to main content
Log in

Optic neuropathy in methylmalonic acidemia: the role of neuroprotection

  • Case Report
  • Published:
Journal of Inherited Metabolic Disease

Abstract

We report the case of a patient with an optic neuropathy induced by neurotoxicity in the setting of methylmalonic acidemia. The patient responded with a significant and long-term improvement in visual acuity, perimetry, and chromatic function after a neuroprotective treatment with vitamin E and coenzyme Q10 was started. Coenzyme Q10 levels had been proven to be normal before starting treatment. This case report is particularly important because it describes a possible treatment for optic neuropathy in methylmalonic patients. Although the response might be, in part, specific to the individual, it suggests the existence of a cause–effect relationship between the treatment undergone by our patient and the improvement in her visual acuity. To date, no other treatments with beneficial effects have been reported for the few optic neuropathies caused by methylmalonic acidemia. Further studies should determine the applicability of coenzyme Q10 and vitamin E for the treatment of optic neuropathies in methylmalonic acidemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

MMA:

Methylmalonic acidemia

MM CoA M:

Methylmalonic–CoA mutase

CoQ10:

Coenzyme Q10

References

  • Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C (2006) Methylmalonic and propionic aciduria. Am J Med Genet Part C Semin Med Genet 142:104–112

    Google Scholar 

  • Yannicelli S (2006) Nutrition therapy of organic acidaemias with amino acid-based formulas: Emphasis on methylmalonic and propionic acidaemia. J Inherit Metab Dis 29:281–287

    Article  PubMed  CAS  Google Scholar 

  • Costeff H, Elpeleg O, Apter N, Divry P, Gadoth N (1993) 3-Methylglutaconic aciduria in “optic athropy plus”. Ann Neurol 33:103–104

    Article  PubMed  CAS  Google Scholar 

  • Patton N, Beatty S, Lloyd IC, Wraith JE (2000) Optic athropy in association with cobalamin C (Cbl C) disease. Ophthalmic Genet 21:151–154

    PubMed  CAS  Google Scholar 

  • Williams ZR, Hurley PE, Altiparmak UE, Feldon SE, Arnold GL, Eggenberger E, Mejico LJ (2009) Late onset optic neuropathy in methylmalonic and propionic acidemia. Am J Ophthalmol 147:929–933

    Article  PubMed  CAS  Google Scholar 

  • Kanaumi T, Takashima S, Hirose S, Kodama T, Iwasaki H (2006) Neuropathology of methylmalonic acidemia in a child. Pediatr Neurol 34:156–159

    Article  PubMed  Google Scholar 

  • Kowaltowski AJ, Maciel EN, Fornazari M, Castilho RF (2006) Diazoxide protects against methylmalonate-induced neuronal toxicity. Exp Neurol 201:165–171

    Article  PubMed  CAS  Google Scholar 

  • Nucci C, Tartaglione R, Cerulli A, Mancino R, Spanò A, Cavaliere F, Rombolà L, Bagetta G, Corasaniti MT, Morrone LA (2007) Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int Rev Neurobiol 82:397–406

    Article  PubMed  CAS  Google Scholar 

  • Russo R, Cavaliere F, Rombolà L, Gliozzi M, Cerulli A, Nucci C, Fazzi E, Bagetta G, Corasaniti MT, Morrone LA (2008) Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection. Prog Brain Res 173:575–582

    Article  PubMed  CAS  Google Scholar 

  • de Keyzer Y, Valayannopoulos V, Benoist JF, Batteux F, Lacaille F, Hubert L, Chrétien D, Chadefeaux-Vekemans B, Niaudet P, Touati G, Munnich A, de Lonlay P (2009) Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res 66(1):91–95

    Article  PubMed  Google Scholar 

  • Fontella FU, Pulrolnik V, Gassen E et al (2000) Propionic and L-methylmalonic acids induce oxidative stress in brain of young rats. NeuroReport 11:541–544

    Article  PubMed  CAS  Google Scholar 

  • Sadun AA (2009) Mitochondrial optic neuropathies. J Neurol Neurosurg Psychiatry 72:423–425

    Google Scholar 

  • Haas D, Niklowitz P, Hörster F et al (2009) Coenzyme Q10 is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria. J Inherit Metab Dis 32(4):570–575

    Google Scholar 

Download references

Acknowledgement

We acknowledge support from O+IKER (Basque Institute for Healthcare Research, Basque Foundation for Healthcare Innovation and Research), Red SAMID (Red de Salud Materno-Infantil y del Desarrollo RD08/0072/0036—Spanish Research Network for Maternal and Child HealtVEPmh and Development).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sergio Pinar-Sueiro.

Additional information

Communicated by: Matthias Baumgartner

References to electronic database: Methylmalonic aciduria: OMIN 251000; Methylmalonyl-CoA mutase: EC 5.4.99.2

Competing interest: None declared.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pinar-Sueiro, S., Martínez-Fernández, R., Lage-Medina, S. et al. Optic neuropathy in methylmalonic acidemia: the role of neuroprotection. J Inherit Metab Dis 33 (Suppl 3), 199–203 (2010). https://doi.org/10.1007/s10545-010-9084-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-010-9084-8

Keywords

Navigation